Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Net Margin (2016 - 2025)

CorMedix (CRMD) has disclosed Net Margin for 14 consecutive years, with 10.9% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 9333.0% to 10.9% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 52.95% through Dec 2025, up 5034.0% year-over-year, with the annual reading at 52.31% for FY2025, 4970.0% up from the prior year.
  • Net Margin hit 10.9% in Q4 2025 for CorMedix, down from 104.08% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 192678.48% in Q2 2023 to a low of 100538.67% in Q3 2022.
  • Historically, Net Margin has averaged 31686.54% across 5 years, with a median of 104.23% in 2024.
  • Biggest five-year swings in Net Margin: soared 17484931bps in 2023 and later tumbled -19443399bps in 2024.
  • Year by year, Net Margin stood at 17141.29% in 2021, then tumbled by -61bps to 27637.7% in 2022, then skyrocketed by 369bps to 74310.64% in 2023, then crashed by -100bps to 104.23% in 2024, then tumbled by -90bps to 10.9% in 2025.
  • Business Quant data shows Net Margin for CRMD at 10.9% in Q4 2025, 104.08% in Q3 2025, and 55.0% in Q2 2025.